NM_001267550.2(TTN):c.98743A>G (p.Ser32915Gly) AND Tibial muscular dystrophy

Clinical significance:Likely benign (Last evaluated: Jan 13, 2018)

Review status:1 star out of maximum of 4 stars

criteria provided, single submitter

Based on:
1 submission [Details]
Record status:
current
Accession:
RCV000276620.2

Allele description [Variation Report for NM_001267550.2(TTN):c.98743A>G (p.Ser32915Gly)]

NM_001267550.2(TTN):c.98743A>G (p.Ser32915Gly)

Genes:
TTN-AS1:TTN antisense RNA 1 [Gene - HGNC]
TTN:titin [Gene - OMIM - HGNC]
Variant type:
single nucleotide variant
Cytogenetic location:
2q31.2
Genomic location:
Preferred name:
NM_001267550.2(TTN):c.98743A>G (p.Ser32915Gly)
HGVS:
  • NC_000002.12:g.178539192T>C
  • NG_011618.3:g.296611A>G
  • NG_051363.1:g.21366T>C
  • NM_001256850.1:c.93820A>G
  • NM_001267550.2:c.98743A>GMANE SELECT
  • NM_003319.4:c.71548A>G
  • NM_133378.4:c.91039A>G
  • NM_133432.3:c.71923A>G
  • NM_133437.4:c.72124A>G
  • NP_001243779.1:p.Ser31274Gly
  • NP_001254479.2:p.Ser32915Gly
  • NP_003310.4:p.Ser23850Gly
  • NP_596869.4:p.Ser30347Gly
  • NP_597676.3:p.Ser23975Gly
  • NP_597681.4:p.Ser24042Gly
  • LRG_391:g.296611A>G
  • NC_000002.11:g.179403919T>C
  • NR_038272.1:n.1142T>C
  • p.Ser30347Gly
Protein change:
S23850G
Links:
dbSNP: rs760917372
NCBI 1000 Genomes Browser:
rs760917372
Molecular consequence:
  • NM_001256850.1:c.93820A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_001267550.2:c.98743A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_003319.4:c.71548A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133378.4:c.91039A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133432.3:c.71923A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NM_133437.4:c.72124A>G - missense variant - [Sequence Ontology: SO:0001583]
  • NR_038272.1:n.1142T>C - non-coding transcript variant - [Sequence Ontology: SO:0001619]

Condition(s)

Name:
Tibial muscular dystrophy (TMD)
Synonyms:
Distal myopathy Markesbery-Griggs type; UDD Myopathy; Tibial muscular dystrophy, tardive; See all synonyms [MedGen]
Identifiers:
MONDO: MONDO:0010870; MedGen: C1838244; Orphanet: 609; OMIM: 600334

Recent activity

Your browsing activity is empty.

Activity recording is turned off.

Turn recording back on

See more...

Assertion and evidence details

Submission AccessionSubmitterReview Status
(Assertion method)
Clinical Significance
(Last evaluated)
OriginMethodCitations
SCV000420421Illumina Clinical Services Laboratory,Illuminacriteria provided, single submitter
Likely benign
(Jan 13, 2018)
germlineclinical testing

Citation Link

Summary from all submissions

EthnicityOriginAffectedIndividualsFamiliesChromosomes testedNumber TestedFamily historyMethod
not providedgermlineunknownnot providednot providednot providednot providednot providedclinical testing

Details of each submission

From Illumina Clinical Services Laboratory,Illumina, SCV000420421.3

#EthnicityIndividualsChromosomes TestedFamily HistoryMethodCitations
1not providednot providednot providednot providedclinical testingnot provided

Description

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as likely benign is not then subjected to further curation. The score for this variant resulted in a classification of likely benign for this disease.

#SampleMethodObservation
OriginAffectedNumber testedTissuePurposeMethodIndividualsAllele frequencyFamiliesCo-occurrences
1germlineunknownnot providednot providednot providednot providednot providednot providednot provided

Last Updated: Dec 2, 2021

Support Center